Macular Edema Treatment Market

Macular Edema Treatment Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Macular edema is the condition characterized by abnormal leakage and accumulation of fluid that
forms blister in the layer of macula. The macula is an oval-shaped pigmented area near the center of
retina. This blister causes the macula to swell and thicken that causes distortion of vision. Although
macular edema has numerous causes, the most common cause is diabetes. Other causes include,
age-related macular degeneration, replacement of lenses in treatment of cataract, chronic uveitis and
intermediate uveitis, blockage of vein in the retina, and congenital diseases including retinitis
pigmentosa and retinoschisis. Symptoms of macular edema include blurry or wavy vision near or in
the center of field of vision. The disease is diagnosed by performing tests such as visual acuity test,
dilated eye exam, fluorescein angiogram, optical coherence tomography, and Amsler grid.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2494
Macular Edema Treatment Market: Drivers
Increasing number of pipeline studies is expected to drive the macular edema treatment market
growth. For instance, in April 2018, University of California, Davis, in collaboration with IRIDEX
Corporation, initiated phase 3 clinical trial for Micropulse Laser Treatment to evaluate micropulse
for suppression of diabetic macular edema (pulse). The primary aim of the study is to determine
whether the micropulse laser treatment in eyes with good visual acuity will improve or stabilize
vision loss due to the complications of diabetic macular edema. The study is expected to be
completed by December 2020.
Macular Edema Treatment Market: Regional Analysis
On the basis of region, the global macular edema treatment market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to account for the largest market share in the macular edema
treatment market, owing to increasing prevalence of diabetic macular edema in this region. For
instance, according to American Journal of Managed Care (AJMC), in 2016, the prevalence rate of
diabetic macular edema was 45.3% in North America.
Moreover, in 2013, as per National Center for Biotechnology Information (NCBI), around 98
million individuals reported for diabetic retinopathy (DR) and 21 million individual reported for
diabetic macular edema (DME) worldwide.
Report includes chapters which deeply display the following deliverable about industry :
• Macular Edema Treatment Market Research Objective and Assumption
• Macular Edema Treatment Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Macular Edema Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Macular Edema Treatment Market, By Regions
• Macular Edema Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Macular Edema Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Macular Edema Treatment Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Macular Edema Treatment Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the macular edema treatment market include, Novartis International
AG, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Pfizer Inc. Bayer AG, Aerpio
Therapeutics, Inc., Biomar Microbial Technologies, Antisense Therapeutics Limited, Coherus
BioSciences, and Bausch & Lomb Incorporated.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2494
Macular Edema Treatment Market Taxonomy
By Disease Type
• Diabetic Macular Edema
• Cystoid Macular Edema
By Drug Class
• Anti-Vascular endothelial growth factor (VEGF) injections
• Avastin
• Eylea
• Lucentis
• Anti-inflammatory Medication
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Corticosteroid
• Ozurdex
• Retisert
• Iluvien
By End User
• Hospitals
• Ophthalmic Clinics
• Research Institutes
By Region
•
•
•
•
•
•
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Download Report